Skip to main content

Table 1 Participant demographic and clinical health characteristics

From: Qualitative interviews with adults with Classic Galactosemia and their caregivers: disease burden and challenges with daily living

Demographic characteristic

Patient total (n = 12)

Caregiver total (n = 8)

Gender

  

 Female

5 (41.7%)

6 (75.0%)

 Male

7 (58.3%)

2 (25.0%)

Agea

  

 Mean (SD)

29.3 (10.24)

55.9 (9.52)

 Median

24.0

55.5

 Q1, Q3

21.5, 38.5

47.0, 64.5

 Min, Max

19, 46

45, 68

Race

  

 White

12 (100%)

8 (100%)

Ethnicity

  

 Not Hispanic/Latino

12 (100%)

8 (100%)

Has caregiver

  

 No

4 (33.3%)

 Yes

8 (66.7%)

Education

  

 High school diploma (or GED)

1 (12.5%)

 Some college or certification program

1 (12.5%)

 College or university degree (2- or 4-year)

5 (62.5%)

 Graduate degree

1 (12.5%)

Work Status

  

 Employed full-time (≥ 40 h per week)

2 (25.0%)

 Employed part-time (< 40 h per week)

1 (12.5%)

 Homemaker

2 (25.0%)

 Retired

3 (37.5%)

Relationship to patient

  

 Parent

8 (100%)

Live with Patient

  

 Yes

5 (62.5%)

 No

3 (37.5%)

GALT enzyme activityb

  

 0.0 nmol/h/mg of hemoglobin

12

GALT gene mutations

  

 Q188R (homozygous)

8

 Q188R, D98N

1

 Q188R, Other

1

 Q188R, K285N

1

 Q188R, L195P

1

  1. GALT galactose-1-phosphate uridylyltransferase; N number of subjects in the population; Q1 25th Percentile; Q3 75th Percentile; SD standard deviation
  2. aPatient age is reported based on year of birth provided via the clinical trial data. Age was calculated using this year and the date of programming (September 2021)
  3. bPatients’ GALT enzyme activity was collected during their enrolment in the ACTION-Galactosemia clinical trial, between August 2019 to August 2021